Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Sign In to gain access to subscriptions and/or personal tools.
Toxicologic Pathology
This Article
Right arrow Abstract Freely available
Right arrow Free Full Text (Free PDF) Free
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Williams, G. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Williams, G. M.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Journal Article

Safety Assessment of Pharmaceuticals: Examples of Inadequate Assessments and a Mechanistic Approach to Assuring Adequate Assessment

Gary M. Williams

American Health Foundation, One Dana Road, Valhalla, New York 10595

For a conventional organic new chemical entity (NCE) being developed as a pharmaceutical, standard regulatory safety assessment studies are required. Early in development, an NCE should undergo a safety/benefit analysis to justify further development. This analysis is made easier and more effective when comprehensive nonclinical data are available. One of the most important aspects of nonclinical toxicologic studies is to provide information on absence of potential carcinogenicity in humans. To avoid human exposures to potentially carcinogenic agents, even in early development of an NCE, the Decision Point Approach to carcinogen testing provides a useful guide to acquisition of mechanistically relevant data for risk assessment.

Key Words: Carcinogenicity • genotoxicity • epigenetic • dantron • methapyrilene • tamoxifen

  • Ashby J. (1991). Determination of the genotoxic status of a chemical. Mutat. Res. 248: 221-231.[Web of Science][Medline] [Order article via Infotrieve]
  • Ashby J. and Tennant RW (1991). Definitive relationships among chemical structure, carcinogenicity and mutagenicity for 301 chemicals tested by the U.S. NTP. Mutat. Res. 257: 229-306.
  • Bird RP, McLellan EA, and Bruce WR (1989). Aberrant crypts, putative precancerous lesions, in the study of the role of diet in the aetiology of colon cancer. Cancer Surv. 8: 189-200.[Web of Science][Medline] [Order article via Infotrieve]
  • Brown JP and Brown RJ (1976). Mutagenesis by 9,10-anthraquinone derivatives and related compounds in Salmonella typhimurium. Mutat. Res. 40: 203-224.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Budunova IV and Williams GM (1994). Cell culture assays for chemicals with tumor-promoting or tumor-inhibiting activity based on the modulation of intercellular communication. Cell Biol. Toxicol. 10: 71-116.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Butterworth BE, Smith-Oliver T., Earle L., et al (1989). Use of primary cultures of human hepatocytes in toxicology studies. Cancer Res. 49: 1075-1084.[Abstract/Free Full Text]
  • Carthew P., Martin EA, White INH, De Matteis F., Edwards RE, Dorman BM, Heydon RT, and Smith LL (1995). Tamoxifen induces short-term cumulative DNA damage and liver tumors in rats: Promotion by phenobarbital. Cancer Res. 55: 544-547.[Abstract/Free Full Text]
  • Casciano DA, Shaddock JG, and Talaska G. (1988). The potent hepatocarcinogen methapyrilene does not form DNA adducts in livers of Fischer 344 rats. Mutat. Res. 208: 129-135.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Davis TS and Monro A. (1995). Marketed human pharmaceuticals reported to be tumorigenic in rodents. J. Am. Coll. Toxicol. 14: 90-107.[Web of Science]
  • Dragan Y., Fahey S., Street K., Vaughan J., Jordon VC, and Pitot HC (1994). Studies of tamoxifen as a promoter of hepatocarcinogenesis in female Fisher F344 rats. Breast Cancer Res. Treat. 31: 11-25.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Ennever F. and Rosenkranz HS (1989). Application of the carcinogenicity prediction and battery selection method to recent national toxicology program short-term test data. Environ. Molec. Mutagen. 13: 332-338.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Furuya K., Mori H., and Williams GM (1983). An enhancing effect of the antihistaminic drug methapyrilene on rat liver carcinogenesis by previously administered N-2-fluorenylacetamide. Tox. Appl. Pharmacol. 70: 49-56.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Gebhardt R. and Williams GM (1995). Glutamine synthetase and hepatocarcinogenesis. Carcinogenesis 16: 2673-2681.
  • Goldsworthy TL, Morgan KT, Popp JA, and Butterworth BE (1991). Guidelines for measuring chemically induced cell proliferation in specific rodent target organs. Progr. Clin. Biol. Res. 369: 253-284.[Web of Science][Medline] [Order article via Infotrieve]
  • Greaves P., Goonetilleke R., Nunn G., Topham J., and Orton T. (1993). Two-year carcinogenicity study of tamoxifen in Alderley Park Wistar-derived rats. Cancer Res. 53: 3919-3924.[Abstract/Free Full Text]
  • Han X. and Liehr JG (1992). Induction of covalent DNA adducts in rodents by tamoxifen. Cancer Res. 52: 1360-1363.[Abstract/Free Full Text]
  • Hard GC, Iatropoulos MJ, Jordan K., Radi L., Kaltenberg OP, Imondi AR, and Williams GM (1993). Major difference in hepatocarcinogenicity and DNA adduct forming activity between toremifene and tamoxifen in female Crl:CD(BR) rats. Cancer Res. 53: 4534-4541.[Abstract/Free Full Text]
  • Hirota N. and Williams GM (1979). The sensitivity and heterogeneity of histochemical markers for altered foci involved in liver carcinogenesis. Am. J. Pathol. 95: 317-378.[Abstract]
  • Hirsimäki P., Hirsimäki Y., Nieminen L., and Payne BJ (1993). Tamoxifen induces hepatocellular carcinoma in rat liver: A 1-year study with two antiestrogens. Arch. Toxicol. 67: 49-54.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Iatropoulos MJ (1992). Accelerated rodent bioassay predictive of chemical carcinogenesis. Exp. Toxicol. Pathol. 44: 481-487.[Web of Science][Medline] [Order article via Infotrieve]
  • Iatropoulos MJ and Williams GM (1996). Proliferation markers. Exp. Toxicol. Pathol. 48: 175-181.[Web of Science][Medline] [Order article via Infotrieve]
  • International Agency for Research on Cancer (1990). IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, Vol. 50, Pharmaceutical Drugs. IARC, Lyon, France.
  • International Agency for Research on Cancer. (1996). IARC Monographs on the Pharmaceuticals, Vol. 66 IARC, Lyon, France (in press).
  • Kitchin KT, Brown JL, and Kulkarni AP (1992). Predictive assay for rodent carcinogenicity using in vivo biochemical parameters: Operational characteristics and complementarily. Mutat. Res. 266: 253-272.[Web of Science][Medline] [Order article via Infotrieve]
  • Lijinsky W., Reuber MD, and Blackwell BN (1980). Liver tumors induced in ras by oral administration of the antihistaminic methapyrilene hydrochloride. Science 209: 817-819.[Abstract/Free Full Text]
  • Lijinsky W. and Yamashita K. (1988). Lack of binding of methapyrilene and similar antihistamines to rat liver DNA examined by 32P-postlabeling. Cancer Res. 48: 6475-6477.[Abstract/Free Full Text]
  • Lutz WK (1979). In vivo covalent binding of organic chemicals to DNA as a quantitative indicator in the process of chemical carcinogenesis. Mutat. Res. 65: 289-356.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Maron D. and Ames BN (1983). Revised methods for the Salmonella mutagenicity test. Mutat. Res. 113: 173-215.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • McQueen CA, Way BM, and Williams GM (1988). Genotoxicity of carcinogens in human hepatocytes; application in hazard assessment. Toxicol. Appl. Pharmacol. 96: 360-366.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Merlino G. (1994). Transgenic mice as models for tumorigenesis. Cancer Invest. 12: 203-213.[Web of Science][Medline] [Order article via Infotrieve]
  • Monro A. (1996). Are lifespan rodent carcinogenicity studies defensible for pharmaceutical agents? Exp. Toxicol. Pathol. 48: 155-166.
  • Montandon F. and Williams GM (1994). Comparison of DNA ractivity of the polyphenylethylene hormonal agents diethylstilbestrol, tamoxifen and toremifene in rat and hamster liver. Arch. Toxicol. 68: 272-275.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Mori H., Ichida T., Tanaka T., and Williams GM (1989). Pathological features of preneoplastic and neoplastic liver lesions in rodents and humans. In: Comparative Ultrastructural Pathology of Selected Tumors in Man and Animals, HM Schuller (ed). CRC Press, Boca Raton, Florida, pp. 61-96.
  • Mori H., Kawai K., Ohbayashi F., Kuniyasu T., Yamazaki M., Hamasaki T., and Williams GM (1984). Genotoxicity of a variety of mycotoxins in the hepatocyte primay culture/DNA repair test using rat and mouse hepatocytes. Cancer Res. 44: 2918-2923.[Abstract/Free Full Text]
  • Mori H., Sugie S., Niwa K., Takahashi M., and Kawai K. (1985). Induction of intestinal tumours in rats by chrysazin. Br. J. Cancer 52: 781-783.
  • Mori H., Sugie S., Niwa K., Yoshimi N., Tanaka T., and Hirono I. (1986). Carcinogenicity of chrysazin in large intestine and liver of mice. Jpn. J. Cancer Res. ( Gann) 77: 871-876.[Web of Science]
  • Müller D., Nelles J., Deparade E., and Arni P. (1980). The activity of S9-liver fractions from seven species in Salmonella/mammalianmicrosome mutagenicity test. Mutat. Res. 70: 279-300.[Web of Science][Medline] [Order article via Infotrieve]
  • Ogiso T., Tatematsu M., Tamano S., Hasegawa R., and Ito N. (1990). Correlation between medium-term liver bioassay system data and results of long-term testing in rats. Carcinogenesis 11: 561-566.[Abstract/Free Full Text]
  • Randerath K. and Randerath E. (1994). 32P-postlabeling methods for DNA adduct detection: Overview and critical evaluation. Drug Metab. Rev. 26: 67-85.[Web of Science][Medline] [Order article via Infotrieve]
  • Richardson FC, Copple DM, and Eacho PI (1992). Effects of methapyrilene on DNA synthesis in mice and rats following continuous dietary exposure. Carcinogenesis 13: 2453-2457.[Abstract/Free Full Text]
  • Sato K., Kitahara S., Satoh K., Khikawa T., Tatematsu M., and Ito N. (1984). The placental form of glutathione S-transferase as a new marker protein for preneoplasia in rat chemical carcinogenesis. Gann 75: 199-202.[Web of Science][Medline] [Order article via Infotrieve]
  • Seilkop SK (1995). The effect of body weight on tumor incidence and carcinogenicity testing in B6C3F1 mice and F344 rats. Fund. Appl. Toxicol. 24: 287-759.
  • Skare JA, Murphy VA, Bookstaff RC, Thompson GA, Heise MA, Horowitz ZD, Powell JH, Parkinson A., and St. Peter JV (1994). Safety assessment of OTC drugs: Doxylamine succinate. Arch. Toxicol Suppl. 17. Eurotox Congress, Basel, Switzerland, pp. 326-340.
  • Trosko JE, Yotti LP, Warren ST, Tsushimoto G., and Chang CC (1982). Inhibition of cell-cell communication by tumor promoters. In: Carcinogenesis, E Hecker, NE Fusenig, W Kunz, F Marks, and HW Thielmann (eds). Raven Press, New York, pp. 565-585.
  • Tucker MJ, Adam HK, and Patterson JS (1984). Tamoxifen. In: Safety Testing of New Drugs, DR Lawrence, AEM McLean, and M Weatherall (eds). Academic Press, New York, pp. 125-162.
  • Weisburger JH and Williams GM (1981). Carcinogen testing, current problems and new approaches. Science 214: 401.[Abstract/Free Full Text]
  • Weisburger JH and Williams GM (1982). Bioassay of carcinogens: In vitro and in vivo tests. In: Chemical Carcinogens, 2nd ed., CE Searle (ed). ACS Monograph 182, American Chemical Society, Washington, D.C., pp. 1323-1373.
  • White INH, de Matteis F., Davies A., Smith LL, Crofton-Sleigh C., Venitt S., Hewer A., and Phillips DH (1992). Genotoxic potential of tamoxifen and analogues in female Fischer F344/n rats, DBA/2 and C57BL/6 mice and in human MCL-5 cells. Carcinogenesis 13: 2197-2203.[Abstract/Free Full Text]
  • Whysner J. and Williams GM (1992). International cancer risk assessment: The impact of biologic mechanisms. Regul. Toxicol. Pharmacol. 15: 41.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Williams GM (1980). The pathogenesis of rat liver cancer caused by chemical carcinogens. Biochem. Biophys. Acta 605: 167-189.[Medline] [Order article via Infotrieve]
  • Williams GM (1987). Definition of a human cancer hazard. In: Nongenotoxic Mechanisms in Carcinogenesis. Banbury Report No. 25, Cold Spring Harbor Laboratory, New York, pp. 367-380.
  • Williams GM (1989). Methods for evaluating chemical genotoxicity. Annu. Rev. Pharmacol. Toxicol. 29: 189-211.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Williams GM (1989). The significance of chemically-induced hepatocellular altered foci in rat liver and application to carcinogen detection. Toxicol. Pathol. 17: 663-674.[Medline] [Order article via Infotrieve]
  • Williams GM (1992). DNA reactive and epigenetic carcinogens. Exp. Toxicol. Pathol. 44: 457-464.[Web of Science][Medline] [Order article via Infotrieve]
  • Williams GM, Iatropoulos MJ, Djordjevic MV, and Kaltenberg OP (1993). The triphenylethylene drug tamoxifen is a strong liver carcinogen in the rat. Carcinogenesis 14: 315-317.[Abstract/Free Full Text]
  • Williams GM, Iatropoulos MJ, and Weisburger JH (1996). Chemical carcinogen mechanisms of action and implications for testing methodology. Exp. Toxicol. Pathol. 48: 9-19.
  • Williams GM, Laspia MF, and Dunkel VC (1982). Reliability of the hepatocyte primary culture/DNA repair test in testing of coded carcinogens and noncarcinogens. Mutat. Res. 97: 359-370.[Web of Science][Medline] [Order article via Infotrieve]
  • Williams GM, Mori H., and McQueen CA (1989). Structure-activity relationships in the rat hepatocyte DNA-repair test for 300 chemicals. Mutat. Res. 221: 263-286.[Web of Science][Medline] [Order article via Infotrieve]
  • Williams GM and Weisburger JH (1981). Systematic carcinogen testing through the Decision Point Approach. Annu. Rev. Pharmacol. Toxicol. 58: 231-235.
  • Williams GM and Weisburger JH (1985). Carcinogenicity testing of drugs. In: Progress in Drug Research, E Jucker (ed). Birkhauser, Verlag, Basel, pp. 155-213.
  • Williams GM and Weisburger JH (1988). Application of the cellular test battery in the Decision Point Approach to carcinogen identification. Mutat. Res. 205: 79-90.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Williams GM and Weisburger JH (1981). Chemical carcinogenesis. In: Casarett and Doull's Toxicology the Basic Sciences of Poisons, 4th ed., MO Amdur, J Doull, and CD Klaassen (eds). Pergamon Press, New York, pp. 127-200.
  • Williams GM and Whysner J. (1996). Epigenetic carcinogens: Evaluation and risk assessment. Exp. Toxicol. Pathol. 48: 89-195.

Toxicologic Pathology, Vol. 25, No. 1, 32-38 (1997)
DOI: 10.1177/019262339702500108
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?



This Article
Right arrow Abstract Freely available
Right arrow Free Full Text (Free PDF) Free
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Williams, G. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Williams, G. M.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?